Aktis Oncology, Inc. (NASDAQ:AKTS) IPO Highlights

Aktis Oncology, Inc. (NASDAQ:AKTS) is a clinical-stage oncology company that has recently made headlines with its initial public offering (IPO). The company focuses on developing innovative cancer treatments, aiming to make a significant impact in the biotech sector. Aktis competes with other biotech firms in the oncology space, striving to bring new therapies to market.Aktis Oncology's IPO involved offering 17.65 million shares at $18 each. The IPO, which took place on January 12, 2026, was upsized, and th ...